Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 5.49 B5.4 B6.01 B6.57 B5.97 B 23.95 B Research & development ————— — Operating income 4.8 B5.21 B4.53 B3.74 B4.5 B 17.98 B Non-Operating Income, Total -962 M-933 M-1 B-1.1 B-1.16 B -4.2 B Interest expense, net of interest capitalized 10 M10 M13 M10 M7 M 40 M Non-Operating Income, excl. Interest Expenses -916 M-922 M-924 M-1.01 B-1.03 B -3.89 B Unusual income/expense -46 M-11 M-78 M-89 M-132 M -310 M Pretax income 3.84 B4.28 B3.53 B2.63 B3.33 B 13.78 B Equity in earnings ————— — Taxes 885 M1.06 B814 M532 M830 M 3.23 B Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 2.95 B3.22 B2.71 B2.1 B2.5 B 10.54 B Discontinued operations ————— — Net income 2.95 B3.22 B2.71 B2.1 B2.5 B 10.54 B Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 2.95 B3.22 B2.71 B2.1 B2.5 B 10.54 B Basic earnings per share (Basic EPS) 2.592.842.421.92.28 9.44 Diluted earnings per share (Diluted EPS) 2.582.842.411.892.27 9.41 Average basic shares outstanding 1.14 B1.13 B1.12 B1.13 B1.1 B — Diluted shares outstanding 1.14 B1.13 B1.13 B1.13 B1.1 B — EBITDA 7.67 B8.09 B7.6 B7.05 B7.89 B 30.63 B EBIT 4.48 B4.95 B4.19 B3.29 B4.07 B 16.5 B Cost of revenue 323 M265 M337 M445 M426 M 1.47 B Other cost of goods sold ————— — Depreciation & amortization (cash flow) 3.2 B3.15 B3.41 B3.76 B3.82 B 14.13 B